Anacor Pharmaceuticals, Inc.

Anacor is a biopharmaceutical company focused on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform, which include topically administered dermatologic compounds. Acquired by Pfizer in 2016.

Select Venture Capital & Financial Partners

Aberdare Ventures Care Capital Red Abbey Venture Partners Rho Acceleration Venrock

www.anacor.com